New Delhi: The U.S. Food and Drug Administration (FDA) has recently approved the use of leucovorin, a drug derived from folic acid, in the treatment of cerebral folate deficiency (CFD), a rare metabolic disorder that can trigger neurological symptoms often resembling those seen in autism. The announcement, published in the Federal Register, coincided with remarks that former U.S. President Donald Trump was expected to make about potential treatments for autism.

Leucovorin, popularly known as folinic acid, is a form of folate that helps cells divide, grow, and function properly. It is also known as vitamin B-9, which helps produce healthy red blood cells and supports immune health as well. During pregnancy, folate is a must for a mother-to-be as its insufficient levels can result in birth defects like neural tube abnormalities. Therefore, the CDC recommends women of childbearing age take........

© News9Live